<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Idiopathic intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> is a disorder of intracerebral pressure regulation and patients run the risk of permanent <z:hpo ids='HP_0000572'>visual loss</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> (IH) has been reported rarely in <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="2" pm="."><plain>We reviewed the medical records of 127 patients with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e>) who were followed up from 1987 to 1996 in our unit </plain></SENT>
<SENT sid="3" pm="."><plain>There were six patients with IH which gave a disease prevalence of 4.7% in those with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> were females giving a disease prevalence of 5.2% for that sex, a high rate of occurrence of IH in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Their age ranged from 22 to 34 y (27.8 +/- 3.6 y) </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0002315'>Headache</z:hpo>, <z:hpo ids='HP_0002013'>vomiting</z:hpo> and <z:hpo ids='HP_0000651'>diplopia</z:hpo> were the common presenting symptoms and had started 7.3 +/- 4.4 weeks prior to the diagnosis of IH </plain></SENT>
<SENT sid="7" pm="."><plain>The cerebrospinal (CSF) opening pressure (413.3 +/- 77.0 mmH2O) was raised in <z:hpo ids='HP_0000001'>all</z:hpo> cases </plain></SENT>
<SENT sid="8" pm="."><plain>Biochemical and cytological analyses of CSF were <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>The only abnormal radiological finding was partially empty sella in one patient on magnetic resonance imaging (MRI) (performed in three patients) or computed tomography (CT) (performed in <z:hpo ids='HP_0000001'>all</z:hpo> patients) </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients had serological evidences of active <z:e sem="disease" ids="C0024141" disease_type="Disease or Syndrome" abbrv="">lupus disease</z:e> at the time of diagnosis of IH </plain></SENT>
<SENT sid="11" pm="."><plain>The renal histology was WHO type IV in four cases and III and V in one each indicating severe renal involvement </plain></SENT>
<SENT sid="12" pm="."><plain>Laboratory evidences of procoagulant activity were found in the form of positive anticardiolipin antibody (aCL) in two patients, <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA) in two and an otherwise unexplained isolated prolongation of activated partial thromboplastin time (APTT) in the other two </plain></SENT>
<SENT sid="13" pm="."><plain>Clinically, one or more episodes of symptomatic venous or <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> had occurred in <z:hpo ids='HP_0000001'>all</z:hpo> subjects </plain></SENT>
<SENT sid="14" pm="."><plain>In addition to symptomatic measures, <z:hpo ids='HP_0000001'>all</z:hpo> subjects were treated with <z:chebi fb="2" ids="8378">prednisolone</z:chebi>, <z:chebi fb="2" ids="2948">azathioprine</z:chebi>, <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> and plasmapheresis according to the protocol of our unit </plain></SENT>
<SENT sid="15" pm="."><plain>One patient who did not receive plasmapheresis and <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> had a relapse while <z:hpo ids='HP_0000001'>all</z:hpo> others recovered completely </plain></SENT>
<SENT sid="16" pm="."><plain>None received <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy </plain></SENT>
<SENT sid="17" pm="."><plain>Young females with serologically active <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>, severe forms of renal lesions, past history of venous or <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> and laboratory evidences of procoagulant activity, appear to be at increased risk of IH </plain></SENT>
<SENT sid="18" pm="."><plain>Thrombotic occlusion of the cerebral arteriolar or venous vascular bed eventually affecting the arachnoid villi and impeding CSF absorption is favoured compared to cerebral venous or sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> as the pathogenic mechanism </plain></SENT>
<SENT sid="19" pm="."><plain>Combined immunosuppression and plasmapheresis appeared to be beneficial in short and long term follow-up </plain></SENT>
<SENT sid="20" pm="."><plain>We propose that patients with SLE and IH have definable risk and pathogenetic factors and are no more to be considered 'idiopathic' </plain></SENT>
<SENT sid="21" pm="."><plain>The conditions calls for aggressive intervention which leads to an excellent outcome </plain></SENT>
</text></document>